Weiyi Peng
The University of Texas MD Anderson Cancer Center(US)The University of Texas Health Science Center at San Antonio(US)Cambridge Electronics (United States)(US)Research Network (United States)(US)University of Houston(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, Immune Cell Function and Interaction
Most-Cited Works
- → Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy(2015)1,506 cited
- → BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma(2013)936 cited
- → Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function(2005)745 cited
- → Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy(2018)611 cited
- → CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade(2018)460 cited
- → Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion(2013)446 cited